Shingles vaccine study for frail patients
Part of Immune system & allergy, Infections clinical trials.
This study tests how well the shingles vaccine works in people with weakened immune systems due to conditions like rheumatoid arthritis, cancer, or multiple sclerosis. It aims to see if the vaccine is safe and effective for these patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a condition like rheumatoid arthritis, cancer (solid tumor or blood cancer), or multiple sclerosis
- You are about to start or are already on certain treatments (like JAK inhibitors, immunotherapy, or immunosuppressants)
- You have not had a shingles vaccine before
- You have no severe infections in the last 3 months
- You are willing to give written consent to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new shingles vaccine in people with psoriasis or myelofibrosis, some of whom take immune-modifying medications. Researchers want to understand how well the vaccine works and how the immune system responds in these groups.
This study tests the recombinant shingles vaccine in adults with autoimmune rheumatic diseases who are on certain mild medications. It aims to see if the vaccine is safe and effective for them.
This study looks at how well the shingles vaccine works in people with autoimmune inflammatory diseases. Researchers want to make sure the vaccine provides good protection for patients whose immune systems are affected by their condition or treatment.
This trial tests a new shingles vaccine for healthy adults 40 and older. It aims to see if the vaccine is safe and helps protect against shingles.
This trial tests whether Shingrix (a shingles vaccine) is safe and works well in adults with rheumatic or immune-related conditions. It compares Shingrix to a placebo (inactive shot) to see how well it prevents shingles and affects immune symptoms.
This trial tests whether the shingles vaccine (RZV) is safe and works well for organ transplant recipients and their household members. It also includes people on dialysis or certain immunosuppressants.
Hear when a new Immunocompromised Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.